Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?
Abstract Background On June 30, 2020, the WHO reported over 10 millions of COVID-19 cases worldwide with over half a million deaths. In severe cases the disease progresses into an Acute Respiratory Distress Syndrome (ARDS), which in turn depends on an overproduction of cytokines (IL-6, TNFα, IL-12,...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-09-01
|
| Series: | Clinical and Molecular Allergy |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12948-020-00132-7 |